A phase 3 randomized, open-label study of OP-1250 monotherapy vs standard of care for the treatment of ER+, HER2– advanced or metastatic breast cancer following endocrine and CDK 4/6 inhibitor therapy (OPERA-01)

Project: Research

NMA HREC Reference Number: 100531
NMA SSA Reference Number: SSA/100531/MonH-2023-391622(v1)
Monash Health Local Reference: RES-23-0000-456A

Status	Active
Effective start/end date	18/10/23 → 17/10/28

Project Details